EUVIMEDObjevte EUVIMED
Open access · CC BY 4.0

Structural Basis of Shiga Toxin Neutralization by Human Antibodies Targeting Canonical Receptor‐Binding and Non‐Canonical Assembly Sites

Jianting Ke, Xin Li iD, Xiaoli Wang, Zhaoxia Huang, Shaojie Xue, Yuyang Liu, Jing Pan, Guowei Hu, Yayu Wang, Cheng Wang iD, Shoudeng Chen iD

Advanced Science · 2026-08-30

DOI: 10.1002/advs.77402 ↗

At a glance

Journal article in Advanced Science, published online on 2026-08-30. Written by Jianting Ke and 10 co-authors. Institution: Division of Nephrology, Department of Medicine, The Fifth Affiliated Hospital, Sun Yat-sen University, Zhuhai, Guangdong, People's Republic of China. Major MEDLINE topics: Antibodies, Monoclonal, Antibodies, Neutralizing, Shiga Toxin, Shiga-Toxigenic Escherichia coli. Cited 1 times so far (Crossref); 37 references. The full text is freely available (open access, CC BY 4.0). Funded by: National Natural Science Foundation of China, National Science and Technology Major Project, Sun Yat-sen University supporting grant.

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

Shiga toxin‐producing Escherichia coli (STEC) infections cause severe systemic complications, yet targeted antitoxin therapeutics remain an unmet clinical need. Here, we isolated a panel of human monoclonal antibodies (mAbs) targeted at STEC toxin and characterized two potent neutralizing candidates, RDS045 and RDS059. The cryo‐electron microscopy structure of the human mAb RDS059 in complex with the Shiga toxin 1a B subunit (Stx1aB) reveals that RDS059 recognizes the surface‐exposed loop of Stx1aB, whereby it directly competes with the host glycolipid globotriaosylceramide (Gb3) to block toxin‐cell engagement. In contrast, RDS045 binds a non‐canonical quaternary epitope at the pentameric interface of Stx1aB, acting as an interprotomer clamp via an extensive hydrogen‐bonding and cation‐π interaction network. Both antibodies confer robust protection in cellular assays and an in vivo murine Stx1a challenge model. Collectively, this work defines two distinct molecular blueprints for Shiga toxin receptor blockade and assembly interference, establishing mechanistic frameworks for the development of STEC therapeutics.

Subjects

MeSH terms (MEDLINE)

Antibodies, MonoclonalAntibodies, NeutralizingShiga ToxinShiga-Toxigenic Escherichia coliShiga Toxin 1Escherichia coli InfectionsHumansAnimalsMiceCryoelectron MicroscopyTrihexosylceramides

Author keywords

Cryo‐EM structureStx1aBhemolytic uremic syndromehuman monoclonal antibodyshiga toxin

Substances

Antibodies, MonoclonalAntibodies, NeutralizingShiga ToxinShiga Toxin 1Trihexosylceramides

Authors and institutions

  • Division of Nephrology, Department of Medicine, The Fifth Affiliated Hospital, Sun Yat-sen University, Zhuhai, Guangdong, People's Republic of China.
  • Department of Experimental Research, The Fifth Affiliated Hospital, Sun Yat-sen University, Zhuhai, Guangdong, People's Republic of China.
  • Zhuhai Trinomab Pharmaceutical Co., Ltd, Zhuhai, Guangdong, People's Republic of China.
  • NHC Key Laboratory of Clinical Nephrology, Sun Yat-Sen University, Guangzhou, Guangdong, People's Republic of China.
  • State Key Laboratory of Anti-Infective Drug Discovery and Development, Sun Yat-sen University, Guangzhou, Guangdong, People's Republic of China.
  • Guangdong Engineering Research Center of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangdong Engineering Technology Research Center of Molecular Imaging, the Fifth Affiliated Hospital, Sun Yat-sen University, Zhuh…

ORCID profiles: Xin Li, Cheng Wang, Shoudeng Chen

Funding

  • National Natural Science Foundation of China
  • National Science and Technology Major Project
  • Sun Yat-sen University supporting grant

Cite

APA

Ke, J., Li, X., Wang, X., Huang, Z., Xue, S., Liu, Y., Pan, J., Hu, G., Wang, Y., Wang, C., & Chen, S. (2026). Structural Basis of Shiga Toxin Neutralization by Human Antibodies Targeting Canonical Receptor‐Binding and Non‐Canonical Assembly Sites. Advanced Science. https://doi.org/10.1002/advs.77402

Vancouver

Ke J, Li X, Wang X, Huang Z, Xue S, Liu Y, et al. Structural Basis of Shiga Toxin Neutralization by Human Antibodies Targeting Canonical Receptor‐Binding and Non‐Canonical Assembly Sites. Advanced Science. 2026. doi:10.1002/advs.77402

BibTeX
@article{Ke2026,
  author = {Ke, Jianting and Li, Xin and Wang, Xiaoli and Huang, Zhaoxia and Xue, Shaojie and Liu, Yuyang and Pan, Jing and Hu, Guowei and Wang, Yayu and Wang, Cheng and Chen, Shoudeng},
  title = {Structural Basis of Shiga Toxin Neutralization by Human Antibodies Targeting Canonical Receptor‐Binding and Non‐Canonical Assembly Sites},
  journal = {Advanced Science},
  year = {2026},
  doi = {10.1002/advs.77402}
}
Start for free →